Skip to main content
ABIVAX Société Anonyme (AAVXF)
OTCMKTS · Delayed Price · Currency is USD
5.81
0.00 (0.00%)
Apr 28, 2025, 4:00 PM EDT

ABIVAX Société Anonyme Revenue

In the year 2024, ABIVAX Société Anonyme had annual revenue of 10.79M EUR with 135.94% growth. ABIVAX Société Anonyme had revenue of 4.01M in the half year ending December 31, 2024, with 78.20% growth.

Revenue
10.79M EUR
Revenue Growth
+135.94%
P/S Ratio
40.43
Revenue / Employee
156.41K EUR
Employees
69
Market Cap
451.77M USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202410.79M6.22M135.94%
Dec 31, 20234.57M69.00K1.53%
Dec 31, 20224.51M302.00K7.19%
Dec 31, 20214.20M4.19M29,921.43%
Dec 31, 202014.00K21.00K-300.00%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.76B
Veradigm 588.02M
Glass House Brands 200.90M
Elite Pharmaceuticals 70.00M
Northwest Biotherapeutics 1.38M
BioStem Technologies 301.83M
American Oncology Network 1.76B
Silence Therapeutics 43.26M
Revenue Rankings

ABIVAX Société Anonyme News

More News